221 related articles for article (PubMed ID: 20652023)
1. Reduced NAA-levels in the NAWM of patients with MS is a feature of progression. A study with quantitative magnetic resonance spectroscopy at 3 Tesla.
Aboul-Enein F; Krssák M; Höftberger R; Prayer D; Kristoferitsch W
PLoS One; 2010 Jul; 5(7):e11625. PubMed ID: 20652023
[TBL] [Abstract][Full Text] [Related]
2. Metabolic changes in normal-appearing white matter in patients with neuromyelitis optica and multiple sclerosis: a comparative magnetic resonance spectroscopy study.
Duan Y; Liu Z; Liu Y; Huang J; Ren Z; Sun Z; Chen H; Dong H; Ye J; Li K
Acta Radiol; 2017 Sep; 58(9):1132-1137. PubMed ID: 28173728
[TBL] [Abstract][Full Text] [Related]
3. Metabolic changes in normal appearing white matter in multiple sclerosis patients using multivoxel magnetic resonance spectroscopy imaging.
Sun J; Song H; Yang Y; Zhang K; Gao X; Li X; Ni L; Lin P; Niu C
Medicine (Baltimore); 2017 Apr; 96(14):e6534. PubMed ID: 28383419
[TBL] [Abstract][Full Text] [Related]
4. (1)H MR spectroscopy of the brain in multiple sclerosis subtypes with analysis of the metabolite concentrations in gray and white matter: initial findings.
Sijens PE; Mostert JP; Oudkerk M; De Keyser J
Eur Radiol; 2006 Feb; 16(2):489-95. PubMed ID: 16028056
[TBL] [Abstract][Full Text] [Related]
5. Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study.
Simone IL; Tortorella C; Federico F; Liguori M; Lucivero V; Giannini P; Carrara D; Bellacosa A; Livrea P
J Neurol Sci; 2001 Jan; 182(2):143-50. PubMed ID: 11137520
[TBL] [Abstract][Full Text] [Related]
6. The association between retinal nerve fibre layer thickness and N-acetyl aspartate levels in multiple sclerosis brain normal-appearing white matter: a longitudinal study using magnetic resonance spectroscopy and optical coherence tomography.
Pardini M; Botzkowski D; Müller S; Vehoff J; Kuhle J; Ruberte E; Würfel J; Gass A; Valmaggia C; Tettenborn B; Putzki N; Yaldizli Ö
Eur J Neurol; 2016 Dec; 23(12):1769-1774. PubMed ID: 27591406
[TBL] [Abstract][Full Text] [Related]
7. Metabolite changes in early relapsing-remitting multiple sclerosis. A two year follow-up study.
Tiberio M; Chard DT; Altmann DR; Davies G; Griffin CM; McLean MA; Rashid W; Sastre-Garriga J; Thompson AJ; Miller DH
J Neurol; 2006 Feb; 253(2):224-30. PubMed ID: 16307201
[TBL] [Abstract][Full Text] [Related]
8. Proton magnetic resonance spectroscopy in primary and secondary progressive multiple sclerosis.
Cucurella MG; Rovira A; Río J; Pedraza S; Tintoré MM; Montalbán X; Alonso J
NMR Biomed; 2000 Apr; 13(2):57-63. PubMed ID: 10797633
[TBL] [Abstract][Full Text] [Related]
9. 1H MRSI comparison of white matter and lesions in primary progressive and relapsing-remitting MS.
Suhy J; Rooney WD; Goodkin DE; Capizzano AA; Soher BJ; Maudsley AA; Waubant E; Andersson PB; Weiner MW
Mult Scler; 2000 Jun; 6(3):148-55. PubMed ID: 10871825
[TBL] [Abstract][Full Text] [Related]
10. Diffusely elevated cerebral choline and creatine in relapsing-remitting multiple sclerosis.
Inglese M; Li BS; Rusinek H; Babb JS; Grossman RI; Gonen O
Magn Reson Med; 2003 Jul; 50(1):190-5. PubMed ID: 12815694
[TBL] [Abstract][Full Text] [Related]
11. MR spectroscopic evidence for glial increase but not for neuro-axonal damage in MS normal-appearing white matter.
Vrenken H; Barkhof F; Uitdehaag BM; Castelijns JA; Polman CH; Pouwels PJ
Magn Reson Med; 2005 Feb; 53(2):256-66. PubMed ID: 15678547
[TBL] [Abstract][Full Text] [Related]
12. Axonal damage but no increased glial cell activity in the normal-appearing white matter of patients with clinically isolated syndromes suggestive of multiple sclerosis using high-field magnetic resonance spectroscopy.
Wattjes MP; Harzheim M; Lutterbey GG; Klotz L; Schild HH; Träber F
AJNR Am J Neuroradiol; 2007 Sep; 28(8):1517-22. PubMed ID: 17846203
[TBL] [Abstract][Full Text] [Related]
13. Correlation of diffusion and metabolic alterations in different clinical forms of multiple sclerosis.
Hannoun S; Bagory M; Durand-Dubief F; Ibarrola D; Comte JC; Confavreux C; Cotton F; Sappey-Marinier D
PLoS One; 2012; 7(3):e32525. PubMed ID: 22479330
[TBL] [Abstract][Full Text] [Related]
14. Relapsing-remitting multiple sclerosis: metabolic abnormality in nonenhancing lesions and normal-appearing white matter at MR imaging: initial experience.
He J; Inglese M; Li BS; Babb JS; Grossman RI; Gonen O
Radiology; 2005 Jan; 234(1):211-7. PubMed ID: 15528260
[TBL] [Abstract][Full Text] [Related]
15. Gray matter N-acetyl aspartate deficits in secondary progressive but not relapsing-remitting multiple sclerosis.
Adalsteinsson E; Langer-Gould A; Homer RJ; Rao A; Sullivan EV; Lima CA; Pfefferbaum A; Atlas SW
AJNR Am J Neuroradiol; 2003; 24(10):1941-5. PubMed ID: 14625214
[TBL] [Abstract][Full Text] [Related]
16. Proton magnetic resonance spectroscopy of normal appearing white matter in familial and sporadic multiple sclerosis.
Siger-Zajdel M; Selmaj KW
J Neurol; 2005 Jul; 252(7):830-2. PubMed ID: 15772740
[TBL] [Abstract][Full Text] [Related]
17. Proton magnetic resonance spectroscopy of normal appearing white matter in asymptomatic relatives of multiple sclerosis patients.
Siger-Zajdel M; Selmaj K
Eur J Neurol; 2006 Mar; 13(3):296-8. PubMed ID: 16618349
[TBL] [Abstract][Full Text] [Related]
18. Proton MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis.
Brex PA; Gomez-Anson B; Parker GJ; Molyneux PD; Miszkiel KA; Barker GJ; MacManus DG; Davie CA; Plant GT; Miller DH
J Neurol Sci; 1999 Jun; 166(1):16-22. PubMed ID: 10465494
[TBL] [Abstract][Full Text] [Related]
19. Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis.
Fernando KT; McLean MA; Chard DT; MacManus DG; Dalton CM; Miszkiel KA; Gordon RM; Plant GT; Thompson AJ; Miller DH
Brain; 2004 Jun; 127(Pt 6):1361-9. PubMed ID: 15128615
[TBL] [Abstract][Full Text] [Related]
20. Localized proton magnetic resonance spectroscopy in relapsing remitting versus secondary progressive multiple sclerosis.
Tourbah A; Stievenart JL; Gout O; Fontaine B; Liblau R; Lubetzki C; Cabanis EA; Lyon-Caen O
Neurology; 1999 Sep; 53(5):1091-7. PubMed ID: 10496272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
